Get started
CITI PHARMA LIMITEDCITI PHARMA LIMITEDCITI PHARMA LIMITED

CITI PHARMA LIMITED

No trades
See on Supercharts
Overview
Financials Ideas Discussions Technicals Seasonals

CPHL chart


Full chart

CPHL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪15.83 B‬ PKR
Dividend yield (indicated)
4.69%
Price to earnings Ratio (TTM)
17.29
Basic EPS (TTM)
4.12 PKR
Net income (FY)
‪833.46 M‬ PKR
Revenue (FY)
‪12.41 B‬ PKR
Shares float
‪78.86 M‬
Beta (1Y)
1.44

Employees


Employees (FY)
615
Change (1Y)
+21 +3.54%
Revenue / Employee (1Y)
‪20.18 M‬ PKR
Net income / Employee (1Y)
‪1.36 M‬ PKR

About CITI PHARMA LIMITED


Sector
Health Technology
CEO
Rizwan Ahmad
Headquarters
Lahore
Website
citipharma.com.pk
Founded
2012
ISIN
PK0126201018
FIGI
BBG011LQGDH1
Citi Pharma Ltd. engages in the manufacturing and sale of pharmaceuticals, medical chemicals, and botanical products. Its products portfolio includes paracetamol, Penicillin/Amoxicillin, Levofloxacin, Cefixime/Cephalosporin, Ciprofloxacin, Cephradine, Norfloxacin, Aspirin, Ibuprofen, and Ascorbic Acid. The company was founded on October 8, 2012 and is headquartered in Lahore, Pakistan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CPHL is 67.99 PKR — it has decreased by −2.68% in the past 24 hours. Watch CITI PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on PSX exchange CITI PHARMA LIMITED stocks are traded under the ticker CPHL.
CPHL stock has fallen by −2.44% compared to the previous week, the month change is a 51.21% rise, over the last year CITI PHARMA LIMITED has showed a 205.57% increase.
CPHL reached its all-time high on Dec 16, 2024 with the price of 73.79 PKR, and its all-time low was 19.07 PKR and was reached on Sep 1, 2023. View more price dynamics on CPHL chart.
See other stocks reaching their highest and lowest prices.
CPHL stock is 2.80% volatile and has beta coefficient of 1.44. Track CITI PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is CITI PHARMA LIMITED there?
Yes, you can track CITI PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
CITI PHARMA LIMITED is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
CPHL net income for the last quarter is ‪201.50 M‬ PKR, while the quarter before that showed ‪152.07 M‬ PKR of net income which accounts for 32.51% change. Track more CITI PHARMA LIMITED financial stats to get the full picture.
Yes, CPHL dividends are paid annually. The last dividend per share was 3.25 PKR. As of today, Dividend Yield (TTM)% is 4.69%. Tracking CITI PHARMA LIMITED dividends might help you take more informed decisions.
CITI PHARMA LIMITED dividend yield was 11.40% in 2024, and payout ratio reached 89.09%. The year before the numbers were 11.72% and 86.80% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 615.00 employees. See our rating of the largest employees — is CITI PHARMA LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CITI PHARMA LIMITED EBITDA is ‪1.54 B‬ PKR, and current EBITDA margin is 9.94%. See more stats in CITI PHARMA LIMITED financial statements.
Like other stocks, CPHL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CITI PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CITI PHARMA LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CITI PHARMA LIMITED stock shows the strong buy signal. See more of CITI PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.